2019
DOI: 10.1007/s40267-019-00611-1
|View full text |Cite
|
Sign up to set email alerts
|

Tamsulosin in urology: beyond benign prostatic hyperplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…All treatment options were discussed extensively with the patient despite his reluctance to receive/undergo endogenous agents or procedures. However, a temporary prescription of the spasmolytic agent tamsulosin was sufficient for protecting against possible urine retention [8]. This regimen was continued for 90 days with serial follow-ups at the urology clinic until discontinuation.…”
Section: Case Reportmentioning
confidence: 99%
“…All treatment options were discussed extensively with the patient despite his reluctance to receive/undergo endogenous agents or procedures. However, a temporary prescription of the spasmolytic agent tamsulosin was sufficient for protecting against possible urine retention [8]. This regimen was continued for 90 days with serial follow-ups at the urology clinic until discontinuation.…”
Section: Case Reportmentioning
confidence: 99%
“…This strategy was applied in the formal synthesis of ( R , R )-formoterol ( 14 ) and ( R )-tamsulosin ( 15 ) (Scheme 5) which have been used as therapeutic drugs for many years [4041]. They are structurally related since they contain an ( R )-1-aryl-2-propanamine moiety.…”
Section: Reviewmentioning
confidence: 99%
“…Tamsulosin, a highly selective α1-blocker, lowers the tone of the smooth muscle contraction in the prostate, urethra, and bladder neck, reducing urine flow resistance [ 3 ]. It has more affinity for α1A receptors than for α1B receptors.…”
Section: Introductionmentioning
confidence: 99%